Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-13
5:02 pm
Sale
13GLyell Immunopharma, Inc.
LYEL
Foresite Capital Fund IV L.P.10,000,000
4%
-3,282,181decrease
(-24.71%)
View
2023-02-09
11:25 am
Purchase
13GLyell Immunopharma, Inc.
LYEL
VANGUARD GROUP INC12,591,230
5.05%
12,591,230increase
(New Position)
View
2022-02-14
4:17 pm
Purchase
13GLyell Immunopharma, Inc.
LYEL
MWG Management Ltd.20,162,332
8.38%
20,162,332increase
(New Position)
View
2022-02-14
4:10 pm
Purchase
13GLyell Immunopharma, Inc.
LYEL
NEWTON (PTC) Ltd15,093,969
6.28%
15,093,969increase
(New Position)
View
2022-02-14
12:04 pm
Purchase
13GLyell Immunopharma, Inc.
LYEL
ARCH Venture Fund IX L.P.36,412,716
15.1%
36,412,716increase
(New Position)
View
2022-02-11
3:10 pm
Purchase
13GLyell Immunopharma, Inc.
LYEL
Foresite Capital Fund IV L.P.13,282,181
5.5%
13,282,181increase
(New Position)
View
2022-02-10
4:51 pm
Purchase
13GLyell Immunopharma, Inc.
LYEL
GSK PLC30,253,189
12.6%
30,253,189increase
(New Position)
View